This company has shut down. SwanBio Therapeutics is no longer operating — its last tracked round was a Venture - Series Unknown in 2023.
Explore the Startup GraveyardSwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
SwanBio Therapeutics has raised $10.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in October 2023.
SwanBio Therapeutics's investors include Partners Innovation Fund, Mass General Brigham Ventures, Syncona Partners LLP.
SwanBio Therapeutics is headquartered in Bala Cynwyd, United States.
SwanBio Therapeutics is a gene therapy company focused on the development and commercialisation of genetically defined therapies.
SwanBio Therapeutics is at the Venture - Series Unknown stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"SwanBio Therapeutics — Funding & Investors." VCBacked, October 4, 2023, https://www.vcbacked.co/company/swanbio-therapeutics. Accessed August 13, 2026.
VCBacked. (2023). SwanBio Therapeutics — Funding & Investors. Retrieved August 13, 2026, from https://www.vcbacked.co/company/swanbio-therapeutics
{{cite web |title=SwanBio Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/swanbio-therapeutics |website=VCBacked |access-date=August 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated